Cargando…
Intrapulmonary administration of recombinant activated factor VII in diffuse alveolar haemorrhage: a report of two case stories
BACKGROUND: Diffuse alveolar haemorrhage (DAH) is a serious pulmonary complication characterised by a high mortality rate and the absence of specific treatment. The intrapulmonary administration of activated recombinant factor VII (rFVIIa) in DAH was recently published in six patients by Heslet et a...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2008
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2551590/ https://www.ncbi.nlm.nih.gov/pubmed/18789132 http://dx.doi.org/10.1186/1757-1626-1-150 |